0000904454-19-000147.txt : 20190204 0000904454-19-000147.hdr.sgml : 20190204 20190204163240 ACCESSION NUMBER: 0000904454-19-000147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190204 DATE AS OF CHANGE: 20190204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIGHAM MICHAEL CENTRAL INDEX KEY: 0001216917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 19564098 MAIL ADDRESS: STREET 1: 890 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 807-6600 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-02-01 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001216917 BIGHAM MICHAEL C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 4TH FLOOR BOSTON MA 02116 1 1 0 0 Chairman and CEO Common Stock 2018-06-21 5 G 0 20050 0 D 236417 D Common Stock 2019-02-01 4 A 0 35000 0 A 271417 D Represents performance-based restricted stock units ("PRSUs") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs will settle in shares of Common Stock on May 8, 2020, provided that the Reporting Person remains in continuous service with Paratek Pharmaceuticals, Inc. through the settlement date. /s/ William M. Haskel, Attorney-in-Fact for Michael Bigham 2019-02-04